Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery. This research report on acute ischemia diagnosis and treatment market explains various advancements occurring in this market and analyzes the global acute ischemic stroke diagnosis and treatment market by diagnosis types and surgery types as well as geographic regions. This report comprises of an elaborate executive summary, which includes a market snapshot that provides a market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram which is drawn that reflects the market size of various segments in descending order.
The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnosis such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, cerebral angiography, nuclear imaging and others. The market for these diagnosis types has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each diagnosis type has been provided for the period 2016 to 2026. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment for the forecast period 2019 to 2026, considering 2018 as the base year.
In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on the surgery types. The segment is categorized into carotid endarterectomy, angioplasty and endovascular mechanical thrombectomy. The market for these surgeries of acute ischemic stroke treatment has been extensively analyzed based on number of surgeries performed and cost of surgery. The market size and forecast in terms of USD million for each segment has been provided for the period 2016 to 2026. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2019 to 2026, considering 2018 as the base year.
Geographically, the acute ischemic stroke diagnosis and treatment market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2016 to 2026 along with CAGR (%) for the forecast period 2019 to 2026. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global acute ischemic stroke diagnosis and treatment market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key players’ market share analysis in 2018 in the acute ischemic stroke diagnosis and treatment market.
This research report also explains about value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, patient). One event impact analysis chart is also includes in this report that describe event and their impact associated with this market from 2016 to 2026.
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report concludes with the profiles of major players in the acute ischemic stroke diagnosis and treatment market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Covidien plc, Johnson and Johnson, Stryker Corporation, Abbott Laboratories, Hitachi Medical Corporation, GE healthcare, Penumbra, Inc. and Philips Healthcare.
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
1.4 List of Abbreviations
Chapter 2 Executive Summary
2.1 Overview
2.2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2018 & 2026)
2.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types , 2018 (USD Million)
2.4 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2018 and 2026 (Value %)
Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
3.3 Market Drivers
3.3.1 Rising number of acute stroke patients aiding the growth of diagnosis and treatment market
3.3.2 Technological innovations in diagnostic and surgical devices boosts market growth
3.4 Restraints
3.4.1 Alternative treatments and high cost are posing a threat for the growth of the market
3.5 Opportunities
3.5.1 Huge potential patient in Asia-Pacific creates opportunity for acute ischemic stroke product developers record high growth in revenue
3.6 Value Chain Analysis
3.7 Porter’s Five Force Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of new entrants
3.7.4 Threat of substitutes
3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
3.9 Competitive Landscape
3.9.1 Market Share Analysis by Key Players, 2018 (Value %)
Chapter 4 Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type
4.1 Overview
4.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2016 – 2026 (USD Million)
4.2 Computed Tomography
4.2.1 Global Computed Tomography Market Revenue, 2016 – 2026 (USD Million)
4.3 Magnetic Resonance Imaging
4.3.1 Global Magnetic Resonance Imaging Market Revenue, 2016 – 2026 (USD Million)
4.4 Ultrasound
4.4.1 Global Ultrasound Market Revenue, 2016 – 2026 (USD Million)
4.5 Cerebral angiography
4.5.1 Global Cerebral Angiography Market Revenue, 2016 – 2026 (USD Million)
4.6 Nuclear Imaging
4.6.1 Global Nuclear Imaging Market Revenue, 2016 – 2026 (USD Million)
4.7 Others
4.7.1 Global Others Market Revenue, 2016 – 2026 (USD Million)
Chapter 5 Acute Ischemic Stroke Diagnosis and Treatment Market by, Surgery Type
5.1 Overview
5.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2016 – 2026 (USD Million)
5.2 Carotid Endarterectomy
5.2.1 Global Carotid Endarterectomy Market Revenue, 2016 – 2026 (USD Million)
5.3 Angioplasty
5.3.1 Global Angioplasty Market Revenue, 2016 – 2026 (USD Million)
5.4 Endovascular Mechanical Thrombectomy
5.4.1 Global Endovascular Mechanical Thrombectomy Market Revenue, 2016 – 2026 (USD Million)
Chapter 6 Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
6.1 Overview
6.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2016 – 2026 (USD Million)
6.2 North America
6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
6.3 Europe
6.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
6.5 Rest of the World
6.5.1 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016 – 2026 (USD Million)
Chapter 7 Recommendations
7.1 Rigorous research and development initiatives for innovative products
7.2 Investing in emerging economies
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Covidien plc
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Johnson & Johnson (Cordis Corporation)
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Penumbra, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Philips Healthcare
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 GE Healthcare
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Hitachi, Ltd.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Siemens Healthcare
8.8.1 Company Overview
8.8.2 Financial overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Stryker Corporation (Concentric Medical, Inc.)
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers